SkinBioTherapeutics Share Forecast, Price & News

Wall Street analysts have given SkinBioTherapeutics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SkinBioTherapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

SkinBioTherapeutics Plc (LON:SBTX) released its earnings results on Tuesday, March, 3rd. The company reported ($0.64) earnings per share for the quarter.
View SkinBioTherapeutics' earnings history.

SkinBioTherapeutics' stock was trading at GBX 8.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SBTX shares have increased by 685.9% and is now trading at GBX 66.80.
View which stocks have been most impacted by COVID-19.

Some companies that are related to SkinBioTherapeutics include Nuvo Pharmaceuticals Inc. (NRI.TO) (NRI), Burcon NutraScience (BU), Aptose Biosciences (APS), Synairgen (SNG), BELLUS Health (BLU), ProMetic Life Sciences (PLI), Neptune Wellness Solutions (NEPT), Emblem (EMC), Medicenna Therapeutics (MDNA), Arix Bioscience (ARIX), Novacyt (NCYT), Bioventix (BVXP), Fennec Pharmaceuticals (FRX), Resverlogix (RVX) and Open Orphan (ORPH).
View all of SBTX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other SkinBioTherapeutics investors own include Anglo Pacific Group (APF), Avacta Group (AVCT), Inspired Energy (INSE), OptiBiotix Health (OPTI), Lb-shell (LBP), Anglo African Oil & Gas (AAOG), Big Sofa Technologies Group (BST), Concepta PLC (CPT.L) (CPT), Fresnillo (FRES) and Shield Therapeutics (STX).

SkinBioTherapeutics trades on the London Stock Exchange (LON) under the ticker symbol "SBTX."

Shares of SBTX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of SBTX stock can currently be purchased for approximately GBX 66.80.

SkinBioTherapeutics has a market capitalization of £104.73 million.

SkinBioTherapeutics employs 7 workers across the globe.

The official website for SkinBioTherapeutics is www.skinbiotherapeutics.com.

SkinBioTherapeutics is headquartered at 15 1 Silk House, Park Green, MACCLESFIELD, SK11 7QJ, United Kingdom.

SkinBioTherapeutics' mailing address is 15 1 Silk House, Park Green, MACCLESFIELD, SK11 7QJ, United Kingdom. The company can be reached via phone at +44-161-4682760.